Author
Listed:
- Christopher Tosh
(Memorial Sloan Kettering Cancer Center)
- Mauricio Tec
(Harvard T.H. Chan School of Public Health)
- Jessica B. White
(Memorial Sloan Kettering Cancer Center)
- Jeffrey F. Quinn
(Memorial Sloan Kettering Cancer Center)
- Glorymar Ibanez Sanchez
(Memorial Sloan Kettering Cancer Center)
- Paul Calder
(Memorial Sloan Kettering Cancer Center)
- Andrew L. Kung
(Memorial Sloan Kettering Cancer Center)
- Filemon S. Dela Cruz
(Memorial Sloan Kettering Cancer Center)
- Wesley Tansey
(Memorial Sloan Kettering Cancer Center)
Abstract
Large-scale combination drug screens are generally considered intractable due to the immense number of possible combinations. Existing approaches use ad hoc fixed experimental designs then train machine learning models to impute unobserved combinations. Here we propose BATCHIE, an orthogonal approach that conducts experiments dynamically in batches. BATCHIE uses information theory and probabilistic modeling to design each batch to be maximally informative based on the results of previous experiments. On retrospective experiments from previous large-scale screens, BATCHIE designs rapidly discover highly effective and synergistic combinations. In a prospective combination screen of a library of 206 drugs on a collection of pediatric cancer cell lines, the BATCHIE model accurately predicts unseen combinations and detects synergies after exploring only 4% of the 1.4M possible experiments. Further, the model identifies a panel of top combinations for Ewing sarcomas, which follow-up validation experiments confirm to be effective, including the rational and translatable top hit of PARP plus topoisomerase I inhibition. These results demonstrate that adaptive experiments can enable large-scale unbiased combination drug screens with a relatively small number of experiments. BATCHIE is open source and publicly available ( https://github.com/tansey-lab/batchie ).
Suggested Citation
Christopher Tosh & Mauricio Tec & Jessica B. White & Jeffrey F. Quinn & Glorymar Ibanez Sanchez & Paul Calder & Andrew L. Kung & Filemon S. Dela Cruz & Wesley Tansey, 2025.
"A Bayesian active learning platform for scalable combination drug screens,"
Nature Communications, Nature, vol. 16(1), pages 1-18, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-024-55287-7
DOI: 10.1038/s41467-024-55287-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-024-55287-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.